Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01529632 · COMPLETED
Trial details
- NCT number
- NCT01529632
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2012-12-01
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.